Release Date: 16/11/09 08:30 Summary: Ceasing to be a substantial holder Price Sensitive: No Download Document 126.71KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%